BioCorRx (BICX) Change in Receivables (2016 - 2025)
BioCorRx (BICX) has disclosed Change in Receivables for 15 consecutive years, with $73796.0 as the latest value for Q4 2025.
- Quarterly Change in Receivables fell 54.34% to $73796.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$108952.0 through Dec 2025, down 42.86% year-over-year, with the annual reading at $52026.0 for FY2025, 168.22% up from the prior year.
- Change in Receivables hit $73796.0 in Q4 2025 for BioCorRx, up from -$73012.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $161638.0 in Q4 2024 to a low of -$271374.0 in Q3 2024.
- Historically, Change in Receivables has averaged -$4426.0 across 5 years, with a median of $1000.0 in 2021.
- Biggest five-year swings in Change in Receivables: surged 19714.0% in 2022 and later tumbled 1884.14% in 2023.
- Year by year, Change in Receivables stood at $500.0 in 2021, then soared by 19714.0% to $99070.0 in 2022, then plummeted by 158.34% to -$57801.0 in 2023, then surged by 379.65% to $161638.0 in 2024, then tumbled by 54.34% to $73796.0 in 2025.
- Business Quant data shows Change in Receivables for BICX at $73796.0 in Q4 2025, -$73012.0 in Q3 2025, and $161638.0 in Q4 2024.